Patterns of Disease Monitoring and Treatment Among Patients With Tuberous Sclerosis Complex-related Angiomyolipomas.
Elyse Swallow, Sarah King, Jinlin Song...
https://pubmed.ncbi.nlm.nih.gov/28263820/Actively Recruiting
Led by National Tuberous Sclerosis Association · Updated on 2026-06-24
5000
Participants Needed
26
Research Sites
N/A
Total Duration
Researchers are collecting and storing blood, DNA, and tissue samples from individuals diagnosed with tuberous sclerosis complex TSC or lymphangioleiomyomatosis LAM to support scientific research. These samples are linked to detailed clinical data that tracks the health impact of TSC over a persons lifetime, gathered both retrospectively and prospectively. This project aims to improve understanding of TSC and related conditions affecting various organs such as the brain, kidney, heart, lungs, and skin. Participants may provide biosamples through various methods, including blood draws, cheek swabs, genetic testing, or tissue donations following routine medical procedures. Samples can be collected at clinical study sites, participants homes, educational meetings, or through approved clinical partners using supplied kits and instructions. All collected samples are sent to a central biobank for processing, storage, and distribution to researchers after appropriate approvals. During participation, individuals contribute their samples and clinical information, which is stored in the TSC Natural History Database. Researchers monitor genetic variants through sequencing and may offer participants genetic counseling if they opt to receive their results. The project involves ongoing collection and sharing of biosamples and data, with an average follow-up of 15 years to study the natural history of TSC and LAM.
CONDITIONS
TSC Biosample Repository and Natural History Database
E
Elizabeth Cassidy, MPH
A
Ayat Abi
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Tuberous Sclerosis Association
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Elyse Swallow, Sarah King, Jinlin Song...
https://pubmed.ncbi.nlm.nih.gov/28263820/Marie Girodengo, Simeon R Mihaylov, Katarzyna Klonowska...
https://pubmed.ncbi.nlm.nih.gov/42162382/Anna Jeong, Jo Anne Nakagawa, Michael Wong
https://pubmed.ncbi.nlm.nih.gov/29129154/Varvara I Rubtsova, Yujin Chun, Joohwan Kim...
https://pubmed.ncbi.nlm.nih.gov/39027368/Mary E Aronow, Jo Anne Nakagawa, Ajay Gupta...
https://pubmed.ncbi.nlm.nih.gov/22608477/Sanjeev V Kothare, Kanwaljit Singh, Tsivia Hochman...
https://pubmed.ncbi.nlm.nih.gov/24754401/Jinlin Song, Elyse Swallow, Qayyim Said...
https://pubmed.ncbi.nlm.nih.gov/30103955/D Ehninger, Y Sano, P J de Vries...
https://pubmed.ncbi.nlm.nih.gov/21079609/Kate Mowrey, Hope Northrup, Peyton Rougeau...
https://pubmed.ncbi.nlm.nih.gov/33897589/Srinivas Chivukula, Omeed Modiri, Alon Kashanian...
https://pubmed.ncbi.nlm.nih.gov/32854808/National Tuberous Sclerosis Association
Lead Sponsor